Figure 5
(A) The number of invasive U2OS cells in each group; (B) images of the invasion of U2OS cells under a light microscope; (C) the number of invasive MG-63 cells in each group; (D) images of the invasion of the MG-63 cells under a light microscope; (E) the number of migrating U2OS cells in each group; (F) images of the migration of U2OS cells under a light microscope; (G) the number of migrating MG-63 cells in each group; (H) images of the migration of the MG-63 cells under a light microscope; n = 3; #, P<0.05 compared with the miR-379 inhibitor NC group; *, P<0.05 compared with the miR-379 mimic NC group; @, P < 0.05 compared with the control shRNA group.
The migration and invasion abilities of U2OS and MG-63 cell lines detected by the Transwell assay

(A) The number of invasive U2OS cells in each group; (B) images of the invasion of U2OS cells under a light microscope; (C) the number of invasive MG-63 cells in each group; (D) images of the invasion of the MG-63 cells under a light microscope; (E) the number of migrating U2OS cells in each group; (F) images of the migration of U2OS cells under a light microscope; (G) the number of migrating MG-63 cells in each group; (H) images of the migration of the MG-63 cells under a light microscope; n = 3; #, P<0.05 compared with the miR-379 inhibitor NC group; *, P<0.05 compared with the miR-379 mimic NC group; @, P < 0.05 compared with the control shRNA group.

Close Modal

or Create an Account

Close Modal
Close Modal